Daniel C. Cochran

432 total citations
7 papers, 352 citations indexed

About

Daniel C. Cochran is a scholar working on Molecular Biology, Ophthalmology and Pharmacology. According to data from OpenAlex, Daniel C. Cochran has authored 7 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Ophthalmology and 2 papers in Pharmacology. Recurrent topics in Daniel C. Cochran's work include Bacillus and Francisella bacterial research (4 papers), Ocular Infections and Treatments (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Daniel C. Cochran is often cited by papers focused on Bacillus and Francisella bacterial research (4 papers), Ocular Infections and Treatments (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Daniel C. Cochran collaborates with scholars based in United States, France and Ireland. Daniel C. Cochran's co-authors include Michelle C. Callegan, Michael S. Gilmore, Didier Lereclus, Myriam Gominet, Harold G. Jensen, Billy D. Novosad, Mebea Aklilu, Stephen B. Tatter, J. Daniel Bourland and Thomas L. Ellis and has published in prestigious journals such as Journal of neurosurgery, Infection and Immunity and Investigative Ophthalmology & Visual Science.

In The Last Decade

Daniel C. Cochran

6 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel C. Cochran United States 6 158 130 74 65 42 7 352
Gunny van Stempvoort Netherlands 13 125 0.8× 5 0.0× 19 0.3× 37 0.6× 63 1.5× 14 463
Won-Il Kim South Korea 9 175 1.1× 16 0.1× 5 0.1× 40 0.6× 21 0.5× 20 368
Willem de Koning Netherlands 9 127 0.8× 3 0.0× 27 0.4× 15 0.2× 12 0.3× 20 246
Sara V. Bernhard Germany 7 77 0.5× 5 0.0× 23 0.3× 31 0.5× 2 0.0× 9 215
Jules Deforges France 14 407 2.6× 3 0.0× 11 0.1× 44 0.7× 10 0.2× 22 551
Jérôme Chenau France 9 222 1.4× 3 0.0× 10 0.1× 57 0.9× 4 0.1× 10 339
Itai Glinert Israel 10 159 1.0× 3 0.0× 79 1.1× 94 1.4× 26 294
Dominique Juy France 10 119 0.8× 3 0.0× 10 0.1× 23 0.4× 6 0.1× 25 409
Ivana Simonović United States 8 266 1.7× 1 0.0× 34 0.5× 85 1.3× 13 0.3× 8 498
Dan Sikkema United States 6 57 0.4× 5 0.0× 3 0.0× 98 1.5× 8 0.2× 6 180

Countries citing papers authored by Daniel C. Cochran

Since Specialization
Citations

This map shows the geographic impact of Daniel C. Cochran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Cochran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Cochran more than expected).

Fields of papers citing papers by Daniel C. Cochran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel C. Cochran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Cochran. The network helps show where Daniel C. Cochran may publish in the future.

Co-authorship network of co-authors of Daniel C. Cochran

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel C. Cochran. A scholar is included among the top collaborators of Daniel C. Cochran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel C. Cochran. Daniel C. Cochran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Cochran, Daniel C., Michael D. Chan, Mebea Aklilu, et al.. (2012). The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. Journal of neurosurgery. 116(5). 978–983. 77 indexed citations
2.
Callegan, Michelle C., et al.. (2006). Virulence Factor Profiles and Antimicrobial Susceptibilities of OcularBacillusIsolates. Current Eye Research. 31(9). 693–702. 44 indexed citations
3.
Callegan, Michelle C., Daniel C. Cochran, Billy D. Novosad, et al.. (2005). BacillusEndophthalmitis: Roles of Bacterial Toxins and Motility during Infection. Investigative Ophthalmology & Visual Science. 46(9). 3233–3233. 58 indexed citations
4.
Callegan, Michelle C., et al.. (2003). Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Advances in Therapy. 20(5). 246–252. 66 indexed citations
5.
Callegan, Michelle C., et al.. (2003). Relationship of plcR -Regulated Factors to Bacillus Endophthalmitis Virulence. Infection and Immunity. 71(6). 3116–3124. 74 indexed citations
6.
Jensen, Harold G., et al.. (2003). Antibacterial Activity of 4th Generation Fluoroquinolones Against Ocular Pathogens. 44(13). 1462–1462.
7.
Callegan, Michelle C., et al.. (2002). Molecular Mechanisms of Bacillus Endophthalmitis Pathogenesis. DNA and Cell Biology. 21(5-6). 367–373. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026